Hospital-based researchers from Denmark have reported a substantial increase in cardiovascular disease risk among male users ...
DUMAGUETE CITY, Negros Oriental (PIA) – The Philippine Health Insurance Corporation (PhilHealth) here has disbursed P469,208,060 as payment for hospital and other medical services claims in the ...
MANILA – Heart attacks and strokes are among the most well-known medical conditions in the Philippines, yet they remain the country’s leading causes of death. Year after year, they claim countless ...
Deadly grip of cardiovascular diseases on Filipino families MANILA, Philippines—Heart attacks and strokes are among the most ...
Vitamin D supplementation shows no significant effect on acute respiratory infections overall, but children and daily low ...
The following is a summary of “Association between impaired brachial flow-mediated dilation and early neurological ...
中国网财经2月25日讯 (记者 段思琦)2月23日,首都医科大学附属北京天坛医院正式启动阿利妥治疗急性缺血性卒中患者的有效性及安全性研——一项随机对照研究:Aleeto in Acute ISchemic Stroke:A RandomISed ...
Flow Space on MSN2 天
The Biggest Threat to Your Life Is Something You've Never Heard of BeforeAccording to the McKinsey Health Institute, the data gap accounts for roughly 8% of the total women's health gap-equivalent ...
2 天
TipRanks on MSNDiaMedica Therapeutics Appoints Daniel J. O’Connor to BoardAn update from Diamedica Therapeutics ( ($DMAC) ) is now available. On February 20, 2025, DiaMedica Therapeutics appointed Daniel J. O’Connor to ...
Schrödinger today announced that management will participate in the following conferences in March: TD Cowen 45th Annual Health Care Conference: Fireside chat on Tuesday, March 4, 2025 at 10:30 a.m. E ...
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on acute ischemic stroke and preeclampsia, today announced the election of Daniel J. O’Connor to its ...
DiaMedica Therapeutics (DMAC) announced the peer-reviewed publication entitled: “Recombinant human tissue kallikrein-1 for treating acute ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果